A Open Label Phase I/II Clinical Trial to Evaluate CPI-613 in Patients With Advanced Malignancies
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Avi Retter, M.D.
Eastchester Center for Cancer Care
Principal Investigator - Divis K Khaira, M.D.
Pivotal Research Centers
Principal Investigator - Karen Gelmon, M.D.
British Columbia Cancer Agency
Principal Investigator - Senzer Neil, M.D.
Mary Crowley Cancer Research Centers
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
4 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- British Columbia Cancer Agency
Vancouver, British Columbia, Canada
- Pivotal Research Centers
Peoria, Arizona, United States
- Eastchester Center for Cancer Care
The Bronx, New York, United States
- Mary Crowley Cancer Research Centers
Dallas, Texas, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 31 Aug 2008
- Primary completion
- 31 Dec 2016
- Completion
- 31 Dec 2016
- Last update posted
- 29 Dec 2016
- Registered enrollment
- 39
- Registry id
- NCT00741403
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.